FDA Class I Recall: Aspergillus Contamination in IV-Start and Convenience Kits
Episode Summary
FDA warned of fungal contamination in certain IV-start kits, prompting facilities to quarantine affected products, trace patient exposures, and assess potential risks of invasive infection.